Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SeqOnce has commercialized multiple genomic tools including rapid NGS library preparation kits and validated qPCR assays. Their products are used by clinical service labs, biotech companies, government labs, and academic institutions. The company pivoted during the COVID‑19 pandemic to supply qPCR reagents for diagnostics. They have generated over $45 million in revenue since founding with a current monthly run rate of $100–250k+. No clinical trial results as products are primarily for research use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SeqOnce Biosciences.